 |
|
Faster radiotherapy more effective in head and neck cancer, trial shows
September 15, 2003The world's largest trial in accelerated radiotherapy for head and neck cancer - the DAHANCA trial - proves conclusively that increasing the number of treatments per week from five to six can benefit patients.
The research is published tomorrow (Saturday 20 September) in The Lancet medical journal[1] and the results will also be presented next week at ECCO 12 - the European Cancer Conference[2], taking place in Copenhagen, Denmark.
Principal investigator Professor Jens Overgaard, from Aarhus University Hospital, Aarhus, Denmark, said that results from DAHANCA meant that the standard radiotherapy treatment for head and neck cancer had now changed.
In the trial, 1,476 head and neck cancer patients were randomised to receive the same amount of radiotherapy per week, the only difference between the groups being the frequency with which they received it. One group had five treatments per week, and the other six. Overall, the results showed a benefit in tumour control of 60% in the 5 x week group, and 70% in the group receiving six treatments. The 6 x week group also showed better voice conservation in the patients with laryngeal cancer (80% as opposed to 68%). The patients were at different stages of the disease, from early to very advanced, but all were indicated for primary radiotherapy.
"Although all patients in the accelerated treatment arm did better," said Professor Overgaard, "some did better than others, and we are currently trying to identify those groups where the benefit is largest. It appears to be linked to two factors - a high degree of expression of epidermal growth factor receptor (EGFR) and a good differentiation of the tumour."
An unpublished meta-analysis of trials[3] of modified fractionated radiotherapy in head and neck cancer, with about 8000 patients in all, also supports these findings, he said. "There are no shades of grey", said Professor Overgaard. These findings are unequivocal - accelerated treatment is definitely better in this cancer, both in terms of disease-specific survival and in quality of life."
Members of DAHANCA - the Danish head and neck cancer group - have been working together for 25 years. "What we have shown is that, with national collaboration and multidisciplinary, co-operative working, it is possible to run large-scale, but inexpensive, trials in small countries which can improve practice throughout the world," said Professor Overgaard.
(ends)
[1]Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. The Lancet. Vol 362. September 20, 2003 pp 933-940.
[2]ECCO 12 abstract no: 1.065 (Thursday 25 September 09.30 hrs CET, FECS/EJC award presentations session)
[3]Abstract no: 678 (Wednesday 24 September 10.45 hrs CET, Head and neck cancer session)
MW Communications
In the trial, 1,476 head and neck cancer patients were randomised to receive the same amount of radiotherapy per week, the only difference between the groups being the frequency with which they received it. One group had five treatments per week, and the other six. Overall, the results showed a benefit in tumour control of 60% in the 5 x week group, and 70% in the group receiving six treatments. The 6 x week group also showed better voice conservation in the patients with laryngeal cancer (80% as opposed to 68%). The patients were at different stages of the disease, from early to very advanced, but all were indicated for primary radiotherapy.
"Although all patients in the accelerated treatment arm did better," said Professor Overgaard, "some did better than others, and we are currently trying to identify those groups where the benefit is largest. It appears to be linked to two factors - a high degree of expression of epidermal growth factor receptor (EGFR) and a good differentiation of the tumour."
An unpublished meta-analysis of trials[3] of modified fractionated radiotherapy in head and neck cancer, with about 8000 patients in all, also supports these findings, he said. "There are no shades of grey", said Professor Overgaard. These findings are unequivocal - accelerated treatment is definitely better in this cancer, both in terms of disease-specific survival and in quality of life."
Members of DAHANCA - the Danish head and neck cancer group - have been working together for 25 years. "What we have shown is that, with national collaboration and multidisciplinary, co-operative working, it is possible to run large-scale, but inexpensive, trials in small countries which can improve practice throughout the world," said Professor Overgaard.
(ends)
[1]Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. The Lancet. Vol 362. September 20, 2003 pp 933-940.
[2]ECCO 12 abstract no: 1.065 (Thursday 25 September 09.30 hrs CET, FECS/EJC award presentations session)
[3]Abstract no: 678 (Wednesday 24 September 10.45 hrs CET, Head and neck cancer session)
MW Communications
Cancer Current Events and Cancer News RSSScientists successfully reprogram blood cells
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
Newly Discovered Fat Molecule: An Undersea Killer with an Upside
A chemical culprit responsible for the rapid, mysterious death of phytoplankton in the North Atlantic Ocean has been found by collaborating scientists at Rutgers University and the Woods Hole Oceanographic Institution (WHOI). This same chemical may hold unexpected promise in cancer research.
For young boys with cancer, testicular tissue banking may be option to preserve fertility
For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility.
CSHL study shows that some malignant tumors can be shut down after all
Oncologists have had their hands tied because more than half of all human cancers have mutations that disable a protein called p53.
Hundreds of genes distinguish patients likely to survive advanced melanoma
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs.
New imagining technique could lead to better antibiotics and cancer drugs
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.
1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.
SNM applauds House action to build medical isotopes reactor in the US
SNM applauds the U.S. House of Representatives for its passage of H.R. 3276-the American Medical Isotopes Production Act of 2009.
More Cancer Current Events and Cancer News Articles
 |
Anticancer: A New Way of Life by David Servan-Schreiber (Author) The New York Times bestseller takes us on an empowering journey and changes the way we think about fighting cancer David Servan-Schreiber's story of his journey from cancer patient to health combines memoir with a clear scientific explanation of what makes cancer cells thrive and what inhibits them. Anticancer is filled with easy to understand charts and diagrams and a sixteen-page color "Anticancer Action" insert that enables readers to make small but essential changes in lifestyle and diet. Your body knows how to fight cancer, says Servan-Schreiber, and you have to help it with nutrition, physical exercise, stress management, and avoiding environmental toxins. Anticancer enables people living with cancer to adopt a proactive attitude to living, even thriving, with cancer and... |
 |
Beating Cancer with Nutrition, book with CD by Patrick Quillin (Author) Beating Cancer with Nutrition. Sugar feeds Cancer: diet and supplements can starve tumors· Nutrition makes chemo and radiation more toxic to the tumor while protecting the patient. Nutrition changes underlying causes of cancer, improving outcome for cancer patients regardless of other therapies. Why Beating Cancer with Nutrition is unique: The book was developed after working with over 500 cancer patients and organizing 3 international symposiums on the subject. The information contained in BCN is both scientifically backed with references and clinically proven in the hospital with patients. This information helps cancer patients to improve quality and quantity of life. BCN had been translated into Japanese and Chinese and is being translated into Korean. BCN had become a home study... |
 |
The Biology of Cancer HB by Robert A. Weinberg (Author) The Biology of Cancer is a new textbook for undergraduate and graduate biology students as well as medical students studying the molecular and cellular bases of cancer. The book presents the principles of cancer biology in an organized, cogent, and in-depth manner. The clarity of writing and the lucid full-color art program make the book accessible and engaging. The information unfolds through the presentation of key experiments which give readers a sense of discovery and provides insights into the conceptual foundation underlying modern cancer biology. The Biology of Cancer synthesizes the findings of three decades of recent cancer research and proposes a conceptual framework from which to teach about these discoveries. It provides the necessary structure, organization, and... |
 |
Pink Snuggie Blanket - Purchase BenefitsThe Breast Cancer Research Foundation by Bewild - Pink Snuggie Blanket |
 |
Cancer: 50 Essential Things to Do: Third Edition by Greg Anderson (Author) The ground-breaking classic guide to surviving cancer—now completely updated! Revised and updated for the first time since 1999, this invaluable guide to cancer recovery offers an easily accessible plan for patients and family members. Written by a cancer survivor, the book is an inspiring, action-oriented roadmap for those who choose to adopt a stance of hope and take charge of their diagnosis. With penetrating insights that bring together more than two decades of scientifically supported research and experience, Anderson reveals a step-by-step holistic action plan that has been successfully employed by hundreds of thousands of cancer patients worldwide. Anderson’s message is: “You must not simply treat illness, you must also create wellness—physically,... |
 |
Butterfly Kisses and Wishes on Wings: When someone you love has cancer...a hopeful, helpful book for kids by Ellen McVicker (Author), Nanci Hersh (Illustrator) This is a listen-to or read-aloud book for children. It is a resource that can be used to educate and support any child who is facing the cancer of aloved one. The story, as told through the eyes of a child, lends itself to a simple and clear understanding of cancer. It also teaches children to realize the power they have to be an active and integral part of a loved one's cancer journey. |
 |
Death Shall Rise by Cancer |
 |
When Someone You Love Has Cancer: A Guide to Help Kids Cope (Elf-Help Books for Kids) by Alaric Lewis (Author), R. W. Alley (Illustrator) |
 |
What to Eat if You Have Cancer (revised): Healing Foods that Boost Your Immune System by Maureen Keane (Author), Daniella Chace (Author) Fuel your body to fight cancer Cancer and cancer treatment take a toll on your body, but you can help make cancer treatment more effective and reduce its unpleasant side effects with good nutrition. What to Eat if You Have Cancer presents the best foods to fight cancer and suggests ways to keep your body strong--knowledge you need to take control of your health. A vital resource for cancer patients, this revised edition contains new recipes, new menus, and the latest research on cancer and nutrition. With the help of What to Eat if You Have Cancer, you will learn The foods to eat and the foods to avoid in your fight with cancer The proper use of supplements in nutrition therapy How to create personalized meal plans to... |
 |
Master Lock 4688DPINK Breast Cancer Research Foundation TSA Resettable Travel Lock, Pink by Master Lock |
| © 2009 BrightSurf.com |